MEDIX BOOST Trademark

Trademark Overview

On Wednesday, January 17, 2024, a trademark application was filed for MEDIX BOOST with the United States Patent and Trademark Office. The USPTO has given the MEDIX BOOST trademark a serial number of 98362207. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, March 26, 2025. The MEDIX BOOST trademark is filed in the Pharmaceutical Products category with the following description:

Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders
medix boost

General Information

Serial Number98362207
Word MarkMEDIX BOOST
Filing DateWednesday, January 17, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateWednesday, March 26, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 15, 2025

Trademark Statements

Goods and ServicesInhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders
Pseudo MarkMEDIX BOOST

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 16, 2024
Primary Code005
First Use Anywhere DateFriday, January 12, 2024
First Use In Commerce DateSunday, January 14, 2024

Trademark Owner History

Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressBAL HARBOUR, FL 33154

Trademark Events

Event DateEvent Description
Wednesday, January 17, 2024NEW APPLICATION ENTERED
Wednesday, May 15, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 19, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 13, 2024ASSIGNED TO EXAMINER
Monday, August 19, 2024NON-FINAL ACTION E-MAILED
Monday, August 19, 2024NON-FINAL ACTION WRITTEN
Monday, August 19, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 7, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 7, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 7, 2024ASSIGNED TO LIE
Tuesday, December 10, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 10, 2024NON-FINAL ACTION E-MAILED
Tuesday, December 10, 2024NON-FINAL ACTION WRITTEN
Monday, February 10, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 14, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 14, 2025FINAL REFUSAL WRITTEN
Friday, March 14, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, March 14, 2025FINAL REFUSAL E-MAILED
Friday, March 14, 2025TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, February 18, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 18, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 9, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 19, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 14, 2025TEAS/EMAIL CORRESPONDENCE ENTERED

Related Keywords

boost medix diseases disorders respiratory treatment pharmaceutical preparations inhaled